Importance of lipid-exposed residues in transmembrane segment four for family B calcitonin receptor homo-dimerization

Regulatory Peptides

Volumn 164, Issue 2-3, 2010, Pages 113-119

  Harikumar, Kaleeckal G ^a   Ball, Alicja M ^a   Sexton, Patrick M ^b   Miller, Laurence J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Binding; Bioluminescence resonance energy transfer; CAMP; Dimerization; G protein coupled receptor; Human calcitonin receptor; Transmembrane helix four; Yellow fluorescent protein

Indexed keywords

ALANINE; AMINO ACID; ARGININE; CALCITONIN RECEPTOR; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; HISTIDINE; ISOLEUCINE; LIPID; PROTEIN TM4; SECRETIN; THREONINE; TRANSMEMBRANE SEGMENT FOUR; TYROSINE; UNCLASSIFIED DRUG; VALINE;

ANIMAL CELL; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIMERIZATION; HUMAN; MUTATIONAL ANALYSIS; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; RABBIT;

AMINO ACID SEQUENCE; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; HUMANS; MICROSCOPY, FLUORESCENCE; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN MULTIMERIZATION; RABBITS; RECEPTORS, CALCITONIN; SEQUENCE HOMOLOGY, AMINO ACID;

ORYCTOLAGUS CUNICULUS;

EID: 77955841797     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.06.001     Document Type: Article

References (35)

1. Gurevich V.V., Gurevich E.V. How and why do GPCRs dimerize?. Trends Pharmacol Sci 2008, 29:234-240.
2. Lohse M.J. Dimerization in GPCR mobility and signaling. Curr Opin Pharmacol 2010, 10:53-58.
3. Milligan G. G protein-coupled receptor hetero-dimerization: contribution to pharmacology and function. Br J Pharmacol 2009, 158:5-14.
4. Harikumar K.G., Morfis M.M., Lisenbee C.S., Sexton P.M., Miller L.J. Constitutive formation of oligomeric complexes between family B G protein-coupled vasoactive intestinal polypeptide and secretin receptors. Mol Pharmacol 2006, 69:363-373.
5. Lisenbee C.S., Miller L.J. Secretin receptor oligomers form intracellularly during maturation through receptor core domains. Biochemistry 2006, 45:8216-8226.
6. Gao F., Harikumar K.G., Dong M., Lam P.C., Sexton P.M., Christopoulos A., Bordner A., Abagyan R., Miller L.J. Functional importance of a structurally distinct homodimeric complex of the family B G protein-coupled secretin receptor. Mol Pharmacol 2009, 76:264-274.
7. Harikumar K.G., Happs R.M., Miller L.J. Dimerization in the absence of higher-order oligomerization of the G protein-coupled secretin receptor. Biochim Biophys Acta 2008, 1778:2555-2563.
8. Harikumar K.G., Pinon D.I., Miller L.J. Transmembrane segment IV contributes a functionally important interface for oligomerization of the Class II G protein-coupled secretin receptor. J Biol Chem 2007, 282:30363-30372.
9. Heroux M., Hogue M., Lemieux S., Bouvier M. Functional calcitonin gene-related peptide receptors are formed by the asymmetric assembly of a calcitonin receptor-like receptor homo-oligomer and a monomer of receptor activity-modifying protein-1. J Biol Chem 2007, 282:31610-31620.
10. Kraetke O., Wiesner B., Eichhorst J., Furkert J., Bienert M., Beyermann M. Dimerization of corticotropin-releasing factor receptor type 1 is not coupled to ligand binding. J Recept Signal Transduct Res 2005, 25:251-276.
11. Langer I., Gaspard N., Robberecht P. Pharmacological properties of Chinese hamster ovary cells coexpressing two vasoactive intestinal peptide receptors (hVPAC1 and hVPAC2). Br J Pharmacol 2006, 148:1051-1059.
12. Pioszak A.A., Harikumar K.G., Parker N.R., Miller L.J., Xu H.E. Dimeric arrangement of the parathyroid hormone receptor and a structural mechanism for ligand-induced dissociation. J Biol Chem 2010, 285:12435-12444.
13. Seck T., Baron R., Horne W.C. The alternatively spliced deltae13 transcript of the rabbit calcitonin receptor dimerizes with the C1a isoform and inhibits its surface expression. J Biol Chem 2003, 278:23085-23093.
14. Harikumar K.G., Morfis M.M., Sexton P.M., Miller L.J. Pattern of intra-family hetero-oligomerization involving the G-protein-coupled secretin receptor. J Mol Neurosci 2008, 36:279-285.
15. Hadac E.M., Ghanekar D.V., Holicky E.L., Pinon D.I., Dougherty R.W., Miller L.J. Relationship between native and recombinant cholecystokinin receptors: role of differential glycosylation. Pancreas 1996, 13:130-139.
16. Harikumar K.G., Hosohata K., Pinon D.I., Miller L.J. Use of probes with fluorescence indicator distributed throughout the pharmacophore to examine the peptide agonist-binding environment of the family B G protein-coupled secretin receptor. J Biol Chem 2006, 281:2543-2550.
17. Munson P.J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem 1980, 107:220-239.
18. Fonseca J.M., Lambert N.A. Instability of a class a G protein-coupled receptor oligomer interface. Mol Pharmacol 2009, 75:1296-1299.
19. Hern J.A., Baig A.H., Mashanov G.I., Birdsall B., Corrie J.E., Lazareno S., Molloy J.E., Birdsall N.J. Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules. Proc Natl Acad Sci USA 2010, 107:2693-2698.
20. Cheng Z.J., Miller L.J. Agonist-dependent dissociation of oligomeric complexes of G protein-coupled cholecystokinin receptors demonstrated in living cells using bioluminescence resonance energy transfer. J Biol Chem 2001, 276:48040-48047.
21. Ding W.Q., Cheng Z.J., McElhiney J., Kuntz S.M., Miller L.J. Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma. Cancer Res 2002, 62:5223-5229.
22. Patel R.C., Kumar U., Lamb D.C., Eid J.S., Rocheville M., Grant M., Rani A., Hazlett T., Patel S.C., Gratton E., Patel Y.C. Ligand binding to somatostatin receptors induces receptor-specific oligomer formation in live cells. Proc Natl Acad Sci USA 2002, 99:3294-3299.
23. Breit A., Lagace M., Bouvier M. Hetero-oligomerization between beta2- and beta3-adrenergic receptors generates a beta-adrenergic signaling unit with distinct functional properties. J Biol Chem 2004, 279:28756-28765.
24. Canals M., Lopez-Gimenez J.F., Milligan G. Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerization-defective alpha(1b)-adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers. Biochem J 2009, 417:161-172.
25. George S.R., Fan T., Xie Z., Tse R., Tam V., Varghese G., O'Dowd B.F. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. J Biol Chem 2000, 275:26128-26135.
26. Han Y., Moreira I.S., Urizar E., Weinstein H., Javitch J.A. Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Nat Chem Biol 2009, 5:688-695.
27. Salahpour A., Angers S., Mercier J.F., Lagace M., Marullo S., Bouvier M. Homodimerization of the beta2-adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem 2004, 279:33390-33397.
28. Terrillon S., Barberis C., Bouvier M. Heterodimerization of V1a and V2 vasopressin receptors determines the interaction with beta-arrestin and their trafficking patterns. Proc Natl Acad Sci USA 2004, 101:1548-1553.
29. Uberti M.A., Hall R.A., Minneman K.P. Subtype-specific dimerization of alpha 1-adrenoceptors: effects on receptor expression and pharmacological properties. Mol Pharmacol 2003, 64:1379-1390.
30. White J.H., Wise A., Main M.J., Green A., Fraser N.J., Disney G.H., Barnes A.A., Emson P., Foord S.M., Marshall F.H. Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature 1998, 396:679-682.
31. Jones K.A., Borowsky B., Tamm J.A., Craig D.A., Durkin M.M., Dai M., Yao W.J., Johnson M., Gunwaldsen C., Huang L.Y., Tang C., Shen Q., Salon J.A., Morse K., Laz T., Smith K.E., Nagarathnam D., Noble S.A., Branchek T.A., Gerald C. GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature 1998, 396:674-679.
32. Guo W., Shi L., Filizola M., Weinstein H., Javitch J.A. Crosstalk in G protein-coupled receptors: changes at the transmembrane homodimer interface determine activation. Proc Natl Acad Sci USA 2005, 102:17495-17500.
33. Harikumar K.G., Dong M., Cheng Z., Pinon D.I., Lybrand T.P., Miller L.J. Transmembrane segment peptides can disrupt cholecystokinin receptor oligomerization without affecting receptor function. Biochemistry 2006, 45:14706-14716.
34. Dorsch S., Klotz K.N., Engelhardt S., Lohse M.J., Bunemann M. Analysis of receptor oligomerization by FRAP microscopy. Nat Meth 2009, 6:225-230.
35. Donnelly D. The arrangement of the transmembrane helices in the secretin receptor family of G-protein-coupled receptors. FEBS Lett 1997, 409:431-436.